Chapter One: Introduction: Access to Medicines as a Human Right – What Does it Mean for Pharmaceutical Industry Responsibilities?
Access to Medicines as a Human Right: Implications for Pharmaceutical Industry Responsibility, Lisa Forman and Jillian Clare Kohler, eds., University of Toronto Press, 2012
23 Pages Posted: 9 Oct 2012
Date Written: October 9, 2010
Forman and Kohler's chapter introduces a new interdisciplinary collection published through the University of Toronto Press which grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The introductory chapter sets the legal and political context for this exploration, looking at the nature of corporate responsibilities within international human rights law and the particular question of the nature of pharmaceutical company responsibilities towards drug access in low and middle-income countries. The chapter overviews the rest of the collection, which brings together scholars and activists from around the world to examine human rights, norms, and ethics in relation to the pharmaceutical sector, consider the tensions between pharmaceutical companies' social and business duties, and complement broad examinations of global conditions with case studies illustrating different approaches for addressing corporate conduct.
Authors include: Asher Alkoby (Ryerson University), Richard Elliott (Canadian HIV/AIDS Legal Network), Lisa Forman (University of Toronto), Paul Hunt (University of Essex), Patricia Illingworth (Northeastern University), Rajat Khosla (Demand Dignity; Amnesty International), Jillian Clare Kohler (University of Toronto), Matthew Lee (Overwaitea Pharmacies), Joel Lexchin (York University), Judith King (Centre for Economic Governance and AIDS in Africa), and Stephanie Nixon (University of Toronto, University of KwaZulu-Natal).
Keywords: right to health, access to medicines, corporate responsibility, global health
Suggested Citation: Suggested Citation